课题基金 / 基金详情

Regulation of differentiation and reproduction of vascular organs by Edg receptor expression

Regulation of differentiation and reproduction of vascular organs by Edg receptor expression
Edg受体表达对血管器官分化和繁殖的调节
批准号:
15590064
负责人:
MURAKI Katsuhiko
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

MURAKI Katsuhiko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Objective: Palmitoyl-L-carnitine (palcar), which accumulates in ischemic heart, affects cellular functions of vascular endothelium in the ischemic area. The aim of the study was to examine the effects of palcar on intracellular Cat^<2+> concentration ([Ca^<2+>]i) in vascular endothelial cells in comparison with those of sphingosine-1-phosphate (S1P) and to investigate the underlying mechanisms. Methods and Results: Human umbilical vein endothelial cells (huvecs) were loaded with Fura-2 AM and the fluorescence signal was measured with Argus 50/CA imaging system. Application of palcar at a concentration range between 0.3 and 3μM elevated [Ca^<2+>]i i in huvecs and its potency was about 30 times lower than that of S1P. Although the sensitivity to palcar and S1P varied widely among huvecs from individuals, response to 3 μM palcar in each huvec clearly paralleled that to 0.3 μM S1P (r=0.79, P<0.001). In addition, huvecs that were treated with 100 ng/ml pertussis toxin (PTX) for 15 hr failed to respond to palcar as well as to S1P, but did respond to 3 μM His. On the other hand, pre-treatment of huvecs with palcar abolished subsequent S1P-induced elevation of [Ca^<2+>]i, but not the His-induced elevation. Conclusions: Our data indicate that palcar has a novel action on huvecs as a potential agonist of receptors for S1P. Effective inhibition of response to S1P by palcar suggests that palcar affects angiogenesis regulated by S1P.
期刊论文(31)
专著(0)
科研奖励(0)
会议论文
Dihydropyridine Ca^<2+> channel antagonists and agonists block Kv4.2, Kv4.3 and Kv1.4 K^+ channels in HEK293 cells
二氢吡啶Ca^2通道拮抗剂和激动剂阻断HEK293细胞中的Kv4.2、Kv4.3和K​​v1.4K^通道
DOI: --
发表时间: 2003
期刊: Br. J. Pharmacol. 139
影响因子: --
作者: [Noriyuki Hatano, Susumu Ohya, Katsuhiko Muraki, Wayne Giles, Yuji Imaizumi]
通讯作者: Yuji Imaizumi
K.Muraki et al.: "A Novel Action of Palmitoyl-L-carnitine in Human Vascular Endothelial Cells."J.Pharmacol.Sci.. 92. 252-258 (2003)
K.Muraki 等人:“棕榈酰-L-肉碱在人血管内皮细胞中的新作用。”J.Pharmacol.Sci.. 92. 252-258 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: 10.1161/01.res.0000097263.10220.0c
发表时间: 2003-10-31
期刊: CIRCULATION RESEARCH
影响因子: 20.1
作者: [Muraki, K, Iwata, Y, Imaizumi, Y]
通讯作者: Imaizumi, Y
Effects of KRN4884, a novel K+ channel opener, on ionic currents in rabbit femoral arterial myocytes.
KRN4884(一种新型 K 通道开放剂)对兔股动脉肌细胞离子电流的影响。
DOI: --
发表时间: 2003
期刊: Journal of Pharmacological Sciences
影响因子: 3.5
作者: [K. Muraki, Akiko Sasaoka, S. Ohya, Minoru Watanabe, Y. Imaizumi]
通讯作者: Y. Imaizumi
20
    Degradation of cation channel and the dysfunction
    • 批准号:
      23590312
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2011
    • 负责人:
      MURAKI Katsuhiko
    • 依托单位:
    Regulation of expression of vascular cation channels by transcriptional and epigenetical modulation
    • 批准号:
      20590263
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2008
    • 负责人:
      MURAKI Katsuhiko
    • 依托单位:
    Relationship between lipid mediator receptors and lipid-induced impairment of human endothelial cells
    • 批准号:
      13672293
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      2001
    • 负责人:
      MURAKI Katsuhiko
    • 依托单位:
    国内基金
    海外基金
    Calcium/NFAT/GLUT3通路调控糖酵解代谢在CAR-T细胞耗竭中的作用和机制研究
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      52万元
    • 批准年份:
      2022
    • 负责人:
      张明明
    • 依托单位:
    钙信号负向调节因子IRBIT抑制肝癌细胞恶性生物学行为的分子机制研究
    • 批准号:
      31960151
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      40.0万元
    • 批准年份:
      2019
    • 负责人:
      徐靖宇
    • 依托单位:
    基于钙信号特征机制的肿瘤转移调控研究
    • 批准号:
      31970729
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2019
    • 负责人:
      魏朝亮
    • 依托单位:
    一种拟南芥IP3结合蛋白作用机制及功能研究
    • 批准号:
      31970723
    • 项目类别:
      面上项目
    • 资助金额:
      60.0万元
    • 批准年份:
      2019
    • 负责人:
      韩生成
    • 依托单位: